Production (Stage)
DarioHealth Corp.
DRIO
$0.7196
$0.00160.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.75M | 7.60M | 7.42M | 6.26M | 5.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.75M | 7.60M | 7.42M | 6.26M | 5.76M |
| Cost of Revenue | 2.00M | 2.11M | 2.20M | 2.27M | 2.16M |
| Gross Profit | 4.76M | 5.49M | 5.22M | 3.99M | 3.60M |
| SG&A Expenses | 9.18M | 9.86M | 10.46M | 12.14M | 13.65M |
| Depreciation & Amortization | 875.00K | 1.29M | 1.34M | 1.23M | 1.16M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.16M | 18.54M | 19.45M | 22.45M | 23.61M |
| Operating Income | -9.41M | -10.94M | -12.03M | -16.19M | -17.86M |
| Income Before Tax | -9.21M | -9.48M | -12.34M | -13.61M | -9.17M |
| Income Tax Expenses | 22.00K | 155.00K | -13.00K | -- | -1.99M |
| Earnings from Continuing Operations | -9.23M | -9.63M | -12.33M | -13.61M | -7.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.23M | -9.63M | -12.33M | -13.61M | -7.18M |
| EBIT | -9.41M | -10.94M | -12.03M | -16.19M | -17.86M |
| EBITDA | -8.15M | -8.38M | -10.32M | -14.35M | -16.53M |
| EPS Basic | -0.14 | -0.12 | -0.25 | -0.08 | -0.20 |
| Normalized Basic EPS | -0.12 | -0.07 | -0.19 | -0.21 | -0.17 |
| EPS Diluted | -0.14 | -0.12 | -0.25 | -0.08 | -0.20 |
| Normalized Diluted EPS | -0.12 | -0.07 | -0.19 | -0.21 | -0.17 |
| Average Basic Shares Outstanding | 47.37M | 78.88M | 40.42M | 39.83M | 34.44M |
| Average Diluted Shares Outstanding | 47.37M | 78.88M | 40.42M | 39.83M | 34.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |